F. Ong

557 total citations
19 papers, 419 citations indexed

About

F. Ong is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, F. Ong has authored 19 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Hematology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in F. Ong's work include Multiple Myeloma Research and Treatments (7 papers), Cancer Treatment and Pharmacology (4 papers) and Advanced Radiotherapy Techniques (4 papers). F. Ong is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Cancer Treatment and Pharmacology (4 papers) and Advanced Radiotherapy Techniques (4 papers). F. Ong collaborates with scholars based in Netherlands, Singapore and France. F. Ong's co-authors include Job van der Palen, Jan J. Jobsen, Hanneke C. Kluin‐Nelemans, J. Hermans, E.M. Noordijk, P. W. Wijermans, J.H. Meerwaldt, Augustinus D. G. Krol, K. van Groningen and H. Struikmans and has published in prestigious journals such as Blood, Food Chemistry and Journal of Clinical Epidemiology.

In The Last Decade

F. Ong

18 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Ong Netherlands 9 213 166 133 95 89 19 419
Kaija Vasala Finland 14 156 0.7× 251 1.5× 120 0.9× 92 1.0× 104 1.2× 27 483
Justus Duyster Germany 8 173 0.8× 145 0.9× 71 0.5× 144 1.5× 55 0.6× 11 490
Enno Dreef Netherlands 11 204 1.0× 190 1.1× 112 0.8× 143 1.5× 39 0.4× 14 489
Paola Ghione United States 14 326 1.5× 254 1.5× 126 0.9× 88 0.9× 28 0.3× 64 594
Sabela Bobillo Spain 11 271 1.3× 206 1.2× 50 0.4× 64 0.7× 61 0.7× 39 437
Vera Vanhentenrijk Belgium 12 374 1.8× 241 1.5× 59 0.4× 144 1.5× 50 0.6× 13 571
Lucas C. M. Arruda Sweden 16 254 1.2× 145 0.9× 38 0.3× 83 0.9× 121 1.4× 28 607
Guido Parvis Italy 13 241 1.1× 197 1.2× 29 0.2× 113 1.2× 90 1.0× 27 437
Haiwen Huang China 11 203 1.0× 234 1.4× 60 0.5× 154 1.6× 100 1.1× 43 491
Finlay MacDougall United Kingdom 7 374 1.8× 352 2.1× 47 0.4× 104 1.1× 98 1.1× 13 680

Countries citing papers authored by F. Ong

Since Specialization
Citations

This map shows the geographic impact of F. Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Ong more than expected).

Fields of papers citing papers by F. Ong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Ong. The network helps show where F. Ong may publish in the future.

Co-authorship network of co-authors of F. Ong

This figure shows the co-authorship network connecting the top 25 collaborators of F. Ong. A scholar is included among the top collaborators of F. Ong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Ong. F. Ong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Loo, Larry Sai Weng, F. Ong, Jiahao Wang, et al.. (2025). Cost-effective production of meaty aroma from porcine cells for hybrid cultivated meat. Food Chemistry. 473. 142946–142946. 6 indexed citations
2.
Wang, Jiahao, et al.. (2024). Perforated imprinting on high moisture meat analogue confers long range mechanical anisotropy resembling meat cuts. npj Science of Food. 8(1). 106–106. 1 indexed citations
3.
Wu, Xiaolin, et al.. (2024). Detection and absolute quantification biosensing tools for food authentication: CRISPR/Cas, digital CRISPR and beyond. Trends in Food Science & Technology. 145. 104349–104349. 7 indexed citations
4.
Pang, Kuin Tian, Larry Sai Weng Loo, Sean Chia, et al.. (2023). Insight into muscle stem cell regeneration and mechanobiology. Stem Cell Research & Therapy. 14(1). 129–129. 22 indexed citations
5.
Ong, F., et al.. (2021). OC-0479 Towards CBCT-guided online adaptive radiotherapy for prostate cancer patients. Radiotherapy and Oncology. 161. S368–S368.
6.
Ong, F., et al.. (2021). PH-0159 Starting a new era in radiotherapy, transition of work from radiation-oncologist to RTT.. Radiotherapy and Oncology. 161. S96–S97. 1 indexed citations
7.
Koch, Sven D., et al.. (2021). PO-1396 CBCT-guided online adaptive radiotherapy: results of the first fifty prostate cancer patients. Radiotherapy and Oncology. 161. S1146–S1147. 1 indexed citations
8.
Wit, E. de, et al.. (2020). Adaptive Radiotherapy Can Be Applied Routinely, Using an Artificial Intelligence Solution, to Treat Prostate Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 108(3). e274–e275. 3 indexed citations
9.
Jobsen, Jan J., Job van der Palen, F. Ong, Sietske A. Riemersma, & H. Struikmans. (2015). Bilateral breast cancer, synchronous and metachronous; differences and outcome. Breast Cancer Research and Treatment. 153(2). 277–283. 59 indexed citations
10.
Jobsen, Jan J., et al.. (2009). The impact of margin status in breast-conserving therapy for lobular carcinoma is age related. European Journal of Surgical Oncology. 36(2). 176–181. 8 indexed citations
11.
Jobsen, Jan J., Job van der Palen, F. Ong, & J.H. Meerwaldt. (2003). Synchronous, bilateral breast cancer: prognostic value and incidence. The Breast. 12(2). 83–88. 79 indexed citations
12.
Ong, F., J. Hermans, E.M. Noordijk, et al.. (1997). Developing a population-based registry for patients with paraproteinemias or multiple myeloma. Journal of Clinical Epidemiology. 50(8). 909–915. 7 indexed citations
13.
Ong, F., et al.. (1997). A population‐based registry on paraproteinaemia in the Netherlands. British Journal of Haematology. 99(4). 914–920. 27 indexed citations
14.
Ong, F., et al.. (1997). Development of a “Myeloma Risk Score” Using a Population-Based Registry on Paraproteinemia and Myeloma. Leukemia & lymphoma. 27(5-6). 495–501. 4 indexed citations
15.
Ong, F., Ulrich Kaiser, J. Hermans, et al.. (1996). Serum neural cell adhesion molecule differentiates multiple myeloma from paraproteinemias due to other causes. Blood. 87(2). 712–716. 15 indexed citations
16.
Ong, F., J. Hermans, E.M. Noordijk, & Hanneke C. Kluin‐Nelemans. (1995). Is the Durie and Salmon diagnostic classification system for plasma cell dyscrasias still the best choice?. Annals of Hematology. 70(1). 19–24. 12 indexed citations
17.
Ong, F., J. Hermans, E.M. Noordijk, P. W. Wijermans, & Hanneke C. Kluin‐Nelemans. (1995). Presenting signs and symptoms in multiple myeloma: High percentages of stage III among patients without apparent myeloma-associated symptoms. Annals of Hematology. 70(3). 149–152. 14 indexed citations
18.
Hermans, J., Augustinus D. G. Krol, K. van Groningen, et al.. (1995). International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades. Blood. 86(4). 1460–1463. 120 indexed citations
19.
Ong, F., et al.. (1995). Bcl-2 protein expression is not related to short survival in multiple myeloma.. PubMed. 9(7). 1282–4. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026